Rare earth metals are an input to most high-tech devices, military and defence systems and electric vehicles. The global race is on to secure supply of these critical minerals. Beat the pack to uncover the 29 best rare earth metal stocks of the very few that mine this essential strategic resource.
To own Ashland, you need to believe in its pivot toward higher value specialty ingredients, supported by stable pharma and personal care demand and ongoing cost savings. The latest earnings setup, with EPS around US$1.03 on roughly 5% revenue growth, reinforces near term focus on margin recovery as the key catalyst, while the biggest current risk remains structurally weaker volumes and pricing in key specialty additives markets; this news does not materially change that risk.
Among recent announcements, the modest dividend increase to US$0.42 per share stands out beside the earnings expectations story. It suggests management is still prioritizing consistent capital returns even as guidance brackets and prior quarters highlight margin pressure and unprofitable periods. For investors, that dividend move sits in tension with concerns about weaker profitability and higher financing needs, especially in light of the new US$500 million revolving credit facility and the activist push for “value maximizing” alternatives.
Yet beneath this improving earnings setup, one risk investors should pay close attention to is...
Read the full narrative on Ashland (it's free!)
Ashland's narrative projects $2.0 billion revenue and $275.8 million earnings by 2029. This requires 4.1% yearly revenue growth and a $960.8 million earnings increase from -$685.0 million today.
Uncover how Ashland's forecasts yield a $70.00 fair value, in line with its current price.
Some of the lowest ranked analysts were already assuming only about 3.2% annual revenue growth and US$200.6 million in earnings by 2029, so if rising regulatory and sustainability costs bite harder than expected after this earnings update, their more pessimistic view of Ashland’s profit potential could gain traction and you may want to compare that against the more optimistic cost saving and innovation story.
Explore another fair value estimate on Ashland - why the stock might be worth just $70.00!
Don't just follow the ticker - dig into the data and build a conviction that's truly your own.
Our daily scans reveal stocks with breakout potential. Don't miss this chance:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com